Disclosure Context

Kabra Drugs Limited submitted a regulatory filing to BSE Limited on 12th June 2026 (Scrip Code: 524322) pursuant to Regulation 30 and 44(3) of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015. The filing contains the Scrutinizer's Report on the results of a Postal Ballot process.

Voting Process Details

  • The Postal Ballot Notice was dated 8th May 2026 and contained two Special Resolutions:

1. To Approve Change in Name of the Company

2. Alteration (Addition) of Object Clause of the Memorandum of Association of The Company

  • The remote e-voting period commenced on Tuesday, 12th May 2026 at 9:00 AM IST and concluded on Wednesday, 10th June 2026 at 5:00 PM IST.
  • The cut-off date for determining shareholder eligibility was Friday, 1st May 2026. Shareholders holding shares as of this date were entitled to vote.
  • The company availed the e-voting facility through CDSL (Central Depository Services Limited).
  • CS Jay Arvind Jain, Proprietor of Jay Jain & Associates, Company Secretaries, was appointed as the Scrutinizer to conduct the Postal Ballot process.

Resolution Voting Results

Resolution 1: To Approve Change in Name of the Company

  • Votes in favor: 2,746,027 votes (99.85% of total valid votes)
  • Votes against: 4,000 votes (0.15% of total valid votes)
  • Total members voted: 35
  • Total valid votes cast: 2,750,027

Resolution 2: Alteration (Addition) of Object Clause of the Memorandum of Association

  • Votes in favor: 2,746,027 votes (99.85% of total valid votes)
  • Votes against: 4,000 votes (0.15% of total valid votes)
  • Total members voted: 35
  • Total valid votes cast: 2,750,027

Outcome and Certification

Both Special Resolutions were approved by the members with the requisite majority. The Scrutinizer's Report was dated 11th June 2026 and was signed by CS Jay Arvind Jain (Membership number: 55129, COP: 23109, Peer Review Certificate No. 6297/2024).

The company's communication was signed by Kuniamuthur Nanjappan Anand, Director (DIN: 03230186), on behalf of Kabra Drugs Limited, with registered office at 208, Swadesh Bhavan, 2 Press Complex, AB Road, Indore, Madhya Pradesh - 452011, India.